/PRNewswire/ - ESSA Pharma Inc. ("ESSA", or the "Company") (Nasdaq: EPIX), a clinical-stage pharmaceutical company focused on developing novel therapies for.
Cybin Announces Closing of Upsized Bought Deal Offering
Company Has Raised Nearly CDN$90 Million to Date NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Cybin Inc. a biotechnology company focused on progressing psychedelic therapeutics, is pleased to announce that it has closed its previously announced bought deal short form prospectus offering including the exercise of the over-allotment option granted to the … Company Has Raised Nearly CDN$90 Million to Date NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Cybin ” or the “ Company ”), a biotechnology company focused on progressing psychedelic therapeutics, is pleased to announce that it has closed its previously announced bought deal short form prospectus offering (the “
Avivagen Inc Announces $5 Million Bought Deal Unit Offering globalbankingandfinance.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globalbankingandfinance.com Daily Mail and Mail on Sunday newspapers.
Press release content from Business Wire. The AP news staff was not involved in its creation.
Titan Medical Announces Closing of US $11.5M Bought Deal Offering Including Full Exercise of Over-Allotment Option
January 26, 2021 GMT
Nasdaq:
TMDI ), a medical device company focused on the design and development of surgical technologies for robotic single access surgery, announced today that it closed its previously announced offering of 6,451,613 units of the Company (“
Units ”) sold on a “bought deal” basis for gross proceeds of approximately US $10,000,000.00 (the “
Offering ”). Bloom Burton Securities Inc. (the “
Underwriter ”) acted as underwriter for the Offering and exercised its over-allotment option in full on the date hereof for an additional 967,741 Units and additional gross proceeds to the Company of approximately US $1,500,000. The aggregate gross proceeds to the Company under the Offering were approximately US $11,500,000.
These Top Penny Stocks Gained Attention on Wednesday; Were You Watching?Â
Wednesday, January 13th was an interesting day for penny stocks. On one hand, we saw many leading names in tech and biotech, get a boost. As a whole, the NASDAQ and NYSE were relatively flat during trading, signaling calm before the coming events. In the next two weeks, political uncertainty will be high yet again in the U.S. After the market closed on Wednesday, the announcement came that the House had voted to impeach President Trump for a second time. While this does not mean immediate impeachment, it is a story that will likely have some kind of impact on the stock market in one way or another. At the present moment, it is difficult to tell just how much penny stocks may be affected, however. Theyâve been relatively insulated from broader trends.Â